AbCellera Biologics Inc. (ABCL) Shareholders’ equity 2019–2025
AbCellera Biologics Inc. (ABCL) shareholders’ equity at each fiscal year-end, per SEC filings.
$966.9MFY2025 · since FY2019: $10.3M → $966.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $966.9M | -8.4% |
| FY2024 | $1.1B | -8.4% |
| FY2023 | $1.2B | -6.6% |
| FY2022 | $1.2B | +20.2% |
| FY2021 | $1.0B | +23.5% |
| FY2020 | $830.5M | +8000.9% |
| FY2019 | $10.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice